Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 6941-6950 Newer>

The Motley Fool December 8, 2010 Seth Jayson	Novo Nordisk Passes This Key Test For the last fully reported fiscal quarter, Novo Nordisk's year-over-year revenue grew 24.5%, and its AR grew 23.5%. That looks OK.
The Motley Fool December 7, 2010 Brian Orelli	How Pfizer's New Chief Can Right the Ship Bigger is not always better.
The Motley Fool December 7, 2010 Roger Friedman	3 Health-Care Winners to Buy A lot's in store for health care stocks in the near future.
The Motley Fool December 7, 2010 Esterhuizen & Sellitti	8 Drug-Related Stocks Being Chased by the Smart Money Looming patent expirations mean lots of generics coming soon.
The Motley Fool December 7, 2010 Seth Jayson	Here's How Merit Medical Systems May Be Failing You With recent TTM operating and net margins below historical averages, Merit Medical Systems has some work to do.
The Motley Fool December 6, 2010 Brian Orelli	3-Month Delay? No Problem! Investors shrug off HGS' Benlysta delay. The Food and Drug Administration's delaying its decision on whether to approve Human Genome Sciences and GlaxoSmithKline's Benlysta shouldn't come as much of a surprise.
The Motley Fool December 6, 2010 Seth Jayson	Why the Street Should Love King Pharmaceuticals' Earnings Over the past 12 months, King Pharmaceuticals generated $276.2 million in FCF on net income of $83.9 million. That means it turned 17.6% of its revenue into FCF. That sounds pretty impressive.
The Motley Fool December 4, 2010 Jeremy Phillips	Time to Sell Varian Medical Systems? Varian has done a good job of reducing its debt over the past five years.
The Motley Fool December 3, 2010 Brian Orelli	Obesity Drug Companies Are (Still) Risky Orexigen heads before an FDA panel.
The Motley Fool December 3, 2010 Travis Hoium	Orexigen Therapeutics Shares Plunged: What You Need to Know Shares of biopharmaceutical company Orexigen Therapeutics fell 10% today after a Food and Drug Administration announcement.
<Older 6941-6950 Newer> Return to current articles.